Us Bancorp \De\ Glaukos Corp Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Glaukos Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 6,099 shares of GKOS stock, worth $684,368. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,099

Previous 5,629 8.35%

Holding current value

$684,368

Previous $733,000 24.69%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$126.42 - $152.67 $59,417 - $71,754	470 Added 8.35%	6,099 $914,000
Q3 2024 Oct 28, 2024	SELL	$113.62 - $135.39 $24,769 - $29,515	-218 Reduced 3.73%	5,629 $733,000
Q2 2024 Aug 06, 2024	BUY	$89.48 - $118.35 $34,628 - $45,801	387 Added 7.09%	5,847 $691,000
Q1 2024 May 07, 2024	SELL	$76.4 - $96.33 $79,685 - $100,472	-1,043 Reduced 16.04%	5,460 $514,000
Q4 2023 Feb 09, 2024	BUY	$59.53 - $85.11 $97,926 - $140,005	1,645 Added 33.86%	6,503 $516,000
Q3 2023 Nov 03, 2023	SELL	$69.23 - $79.09 $415 - $474	-6 Reduced 0.12%	4,858 $365,000
Q2 2023 Aug 09, 2023	SELL	$45.44 - $71.21 $3,453 - $5,411	-76 Reduced 1.54%	4,864 $346,000
Q1 2023 May 09, 2023	BUY	$43.88 - $52.48 $438 - $524	10 Added 0.2%	4,940 $247,000
Q4 2022 Feb 13, 2023	SELL	$40.82 - $57.75 $9,470 - $13,398	-232 Reduced 4.49%	4,930 $215,000
Q3 2022 Oct 27, 2022	SELL	$46.84 - $58.49 $327 - $409	-7 Reduced 0.14%	5,162 $275,000
Q2 2022 Aug 01, 2022	BUY	$34.86 - $63.77 $69 - $127	2 Added 0.04%	5,169 $235,000
Q1 2022 May 11, 2022	SELL	$44.33 - $57.82 $177 - $231	-4 Reduced 0.08%	5,167 $299,000
Q4 2021 Feb 11, 2022	SELL	$40.27 - $56.99 $15,987 - $22,625	-397 Reduced 7.13%	5,171 $230,000
Q3 2021 Nov 10, 2021	SELL	$47.43 - $84.23 $19,019 - $33,776	-401 Reduced 6.72%	5,568 $268,000
Q2 2021 Aug 05, 2021	BUY	$73.06 - $97.7 $396,861 - $530,706	5,432 Added 1011.55%	5,969 $506,000
Q1 2021 Apr 28, 2021	SELL	$70.43 - $97.42 $4,789 - $6,624	-68 Reduced 11.24%	537 $45,000
Q4 2020 Feb 04, 2021	BUY	$48.9 - $75.26 $733 - $1,128	15 Added 2.54%	605 $45,000
Q3 2020 Nov 10, 2020	BUY	$37.23 - $50.97 $12,732 - $17,431	342 Added 137.9%	590 $29,000
Q2 2020 Aug 07, 2020	BUY	$28.78 - $46.83 $6,417 - $10,443	223 Added 892.0%	248 $10,000
Q1 2020 May 13, 2020	BUY	$25.53 - $70.14 $638 - $1,753	25 New	25 $1,000
Q3 2018 Nov 01, 2018	SELL	$38.13 - $68.37 $22,878 - $41,022	-600 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$27.62 - $44.51 $16,737 - $26,973	-606 Reduced 50.25%	600 $24,000
Q1 2018 May 08, 2018	BUY	$26.05 - $34.5 $31,416 - $41,607	1,206 New	1,206 $37,000

Others Institutions Holding GKOS

# of Institutions

355

Shares Held

50.1M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $5.34B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account